Related Experiment Videos
Effects of lithium on the kidney
Acta Psychiatrica Scandinavica
|January 1, 1987
Summary
Lithium treatment for mood disorders showed no serious kidney damage in patients. While some kidney function markers slightly differed, these changes were not statistically significant, suggesting lithium
Area of Science:
- Nephrology
- Psychiatry
- Pharmacology
Background:
- Lithium is a common mood stabilizer for bipolar disorder.
- Long-term lithium use raises concerns about potential kidney toxicity.
- Assessing renal function in patients on lithium is crucial for patient safety.
Purpose of the Study:
- To evaluate kidney function in patients undergoing long-term lithium treatment.
- To compare renal function between lithium-treated patients and a control group.
- To identify potential risk factors for kidney impairment during lithium therapy.
Main Methods:
- Kidney function tests were performed on 268 patients receiving lithium treatment.
- A control group of 59 patients with manic-depressive illness not on lithium was included.
- Parameters assessed included maximum concentrating capacity and serum creatinine levels.
Main Results:
- No patients experienced severe renal damage during the study period.
- Lithium-treated patients showed slightly lower concentrating capacity and higher serum creatinine than controls, but differences lacked statistical significance.
- Female patients exhibited poorer concentrating ability than males in both groups.
Conclusions:
- Long-term lithium treatment, at the dosages and duration studied, did not result in significant renal damage.
- Subtle, non-significant changes in kidney function were observed in lithium-treated patients.
- Concomitant antipsychotic medication may negatively impact renal function and concentrating ability.